C WorldWide Group Holding A/S
Position in NBIX — Neurocrine Biosciences Inc
CIK 1625244
COPENHAGEN, G7
Position in NBIX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$16,467,500
-$1,261,250 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026C WorldWide Group Holding A/S holds $25,307,500 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (65.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
125,000 | $16,467,500 | |
| 2 | ALKS |
Alkermes plc.
|
250,000 | $8,840,000 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,467,500 | 125,000 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $17,728,750 | 125,000 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $17,547,500 | 125,000 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $16,968,150 | 135,000 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $12,719,000 | 115,000 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $15,697,500 | 115,000 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $10,945,900 | 95,000 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $10,325,250 | 75,000 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||